Similarly lethal strains of extraintestinal pathogenic Escherichia coli trigger markedly diverse host responses in a zebrafish model of sepsis

mSphere

Volumn 1, Issue 2, 2016, Pages

  Barber, Amelia E ^a   Fleming, Brittany A ^a   Mulvey, Matthew A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Bloodstream infections; Cytokine storm; Escherichia coli; ExPEC; Flagellin; Sepsis; TLR5; Zebrafish

Indexed keywords

EID: 85014938481     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00062-16     Document Type: Article

References (106)

1. Smith JL, Fratamico PM, Gunther NW. 2007. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 4:134-163. http:// dx.doi.org/10.1089/fpd.2007.0087
2. Laupland KB. 2013. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 19:492-500. http:// dx.doi.org/10.1111/1469-0691.12144
3. Ron EZ. 2010. Distribution and evolution of virulence factors in septicemic Escherichia coli. Int J Med Microbiol 300:367-370. http:// dx.doi.org/10.1016/j.ijmm.2010.04.009
4. Mellata M. 2013. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends. Foodborne Pathog Dis 10:916-932. http://dx.doi.org/10.1089/ fpd.2013.1533
5. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. 2014. Early-onset neonatal sepsis. Clin Microbiol Rev 27:21-47. http:// dx.doi.org/10.1128/CMR.00031-13
6. van der Mee-Marquet NL, Blanc DS, Gbaguidi-Haore H, Dos Santos Borges S, Viboud Q, Bertrand X, Quentin R. 2015. Marked increase in incidence for bloodstream infections due to Escherichia coli, a side effect of previous antibiotic therapy in the elderly. Front Microbiol 6:646. http://dx.doi.org/10.3389/fmicb.2015.00646
7. Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. 2011. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief 62:1-8
8. Maslove DM, Wong HR. 2014. Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med 20: 204-213. http://dx.doi.org/10.1016/j.molmed.2014.01.006
9. Burdet C, Clermont O, Bonacorsi S, Laouénan C, Bingen E, Aujard Y, Mentré F, Lefort A, Denamur E, COLIBAFI Group. 2014. Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity. Pediatr Infect Dis J 33:872-879. http:// dx.doi.org/10.1097/INF.0000000000000309
10. Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentré F, Fantin B, Wolff M, Denamur E, COLIBAFI Group. 2011. Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49:777-783. http://dx.doi.org/10.1128/JCM.01902-10
11. Martínez JA, Soto S, Fabrega A, Almela M, Mensa J, Soriano A, Marco F, Jimenez de Anta MT, Vila J. 2006. Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. J Clin Microbiol 44:1468-1474. http:// dx.doi.org/10.1128/JCM.44.4.1468-1474.2006
12. Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H. 2010. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 14:R27. http://dx.doi.org/10.1186/cc8898
13. Gao H, Evans TW, Finney SJ. 2008. Bench-to-bedside review: sepsis, severe sepsis and septic shock-does the nature of the infecting organism matter? Crit Care 12:213. http://dx.doi.org/10.1186/cc6862
14. Wiles TJ, Norton JP, Russell CW, Dalley BK, Fischer KF, Mulvey MA. 2013. Combining quantitative genetic footprinting and trait enrichment analysis to identify fitness determinants of a bacterial pathogen. PLoS Genet 9 :e1003716. h t t p: / / d x . d o i . o r g / 1 0 . 1 3 7 1 / journal.pgen.1003716
15. Wiles TJ, Norton JP, Smith SN, Lewis AJ, Mobley HL, Casjens SR, Mulvey MA. 2013. A phyletically rare gene promotes the niche-specific fitness of an E. coli pathogen during bacteremia. PLoS Pathog 9:e1003175. http://dx.doi.org/10.1371/journal.ppat.1003175
16. Subashchandrabose S, Smith SN, Spurbeck RR, Kole MM, Mobley HL. 2013. Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog 9:e1003788. http://dx.doi.org/10.1371/journal.ppat.1003788
17. Vigil PD, Wiles TJ, Engstrom MD, Prasov L, Mulvey MA, Mobley HL. 2012. The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia. Infect Immun 80:493-505. http://dx.doi.org/10.1128/IAI.05713-11
18. Smith SN, Hagan EC, Lane MC, Mobley HLT. 2010. Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. mBio 1:e00262-10. http://dx.doi.org/10.1128/ mBio.00262-10
19. Marcq I, Martin P, Payros D, Cuevas-Ramos G, Boury M, Watrin C, Nougayrède JP, Olier M, Oswald E. 2014. The genotoxin colibactin exacerbates lymphopenia and decreases survival rate in mice infected with septicemic Escherichia coli. J Infect Dis 210:285-294. http:// dx.doi.org/10.1093/infdis/jiu071
20. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. 2012. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 80:1554-1562. http://dx.doi.org/ 10.1128/IAI.06388-11
21. Salipante SJ, Roach DJ, Kitzman JO, Snyder MW, Stackhouse B, Butler-Wu SM, Lee C, Cookson BT, Shendure J. 2015. Large-scale genomic sequencing of extraintestinal pathogenic Escherichia coli strains. Genome Res 25:119-128. http://dx.doi.org/10.1101/ gr.180190.114
22. Skjøt-Rasmussen L, Ejrnaes K, Lundgren B, Hammerum AM, Frimodt-Møller N. 2012. Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital-vs. community-acquired origin. Int J Med Microbiol 302:129-134. http://dx.doi.org/10.1016/ j.ijmm.2012.03.002
23. Johnson JR, Kuskowski MA, O'Bryan TT, Maslow JN. 2002. Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diversesource bacteremia. J Infect Dis 185:1439-1447. http://dx.doi.org/ 10.1086/340506
24. Landraud L, Jauréguy F, Frapy E, Guigon G, Gouriou S, Carbonnelle E, Clermont O, Denamur E, Picard B, Lemichez E, Brisse S, Nassif X. 2013. Severity of Escherichia coli bacteraemia is independently of the intrinsic virulence of the strains assessed in a mouse model. Clin Microbiol Infect 19:85-90. http://dx.doi.org/10.1111/j.1469-0691.2011.03750.x
25. Mokady D, Gophna U, Ron EZ. 2005. Extensive gene diversity in septicemic Escherichia coli strains. J Clin Microbiol 43:66-73. http:// dx.doi.org/10.1128/JCM.43.1.66-73.2005
26. Jaureguy F, Landraud L, Passet V, Diancourt L, Frapy E, Guigon G, Carbonnelle E, Lortholary O, Clermont O, Denamur E, Picard B, Nassif X, Brisse S. 2008. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 9:560. http:// dx.doi.org/10.1186/1471-2164-9-560
27. Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, Bidet P, Bingen E, Bonacorsi S, Bouchier C, Bouvet O, Calteau A, Chiapello H, Clermont O, Cruveiller S, Danchin A, Diard M, Dossat C, Karoui ME, Frapy E, Garry L, Ghigo JM, Gilles AM, Johnson J, Le Bouguenec C, Lescat M, Mangenot S, Martinez-Jehanne V, Matic I, Nassif X, Oztas S, Petit MA, Pichon C, Rouy Z, Ruf CS, Schneider D, Tourret J, Vacherie B, Vallenet D, Medigue C, Rocha EP, Denamur E. 2009. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 5:e1000344. http:// dx.doi.org/10.1371/journal.pgen.1000344
28. Rasko DA, Rosovitz MJ, Myers GS, Mongodin EF, Fricke WF, Gajer P, Crabtree J, Sebaihia M, Thomson NR, Chaudhuri R, Henderson IR, Sperandio V, Ravel J. 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 190:6881-6893. http://dx.doi.org/ 10.1128/JB.00619-08
29. Wiles TJ, Bower JM, Redd MJ, Mulvey MA. 2009. Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog 5:e1000697. http://dx.doi.org/10.1371/journal.ppat.1000697
30. Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, Denamur E. 2006. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis 194:1141-1150. http://dx.doi.org/10.1086/ 507305
31. van der Vaart M, Spaink HP, Meijer AH. 2012. Pathogen recognition and activation of the innate immune response in zebrafish. Adv Hematol 2012:159807. http://dx.doi.org/10.1155/2012/159807
32. Renshaw SA, Trede NS. 2012. A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech 5:38-47. http://dx.doi.org/10.1242/dmm.007138
33. Phan MD, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, Gomes Moriel D, Achard ME, Totsika M, Marshall VM, Upton M, Beatson SA, Schembri MA. 2013. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet 9:e1003834. http://dx.doi.org/10.1371/journal.pgen.1003834
34. Lloyd AL, Rasko DA, Mobley HL. 2007. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189:3532-3546. http://dx.doi.org/10.1128/JB.01744-06
35. Sorrells S, Toruno C, Stewart RA, Jette C. 2013. Analysis of apoptosis in zebrafish embryos by whole-mount immunofluorescence to detect activated caspase 3. J Vis Exp 82:e51060. http://dx.doi.org/10.3791/ 51060
36. Gong Z, Ju B, Wang X, He J, Wan H, Sudha PM, Yan T. 2002. Green fluorescent protein expression in germ-line transmitted transgenic zebrafish under a stratified epithelial promoter from keratin8. Dev Dyn 223:204-215. http://dx.doi.org/10.1002/dvdy.10051
37. Lawson ND, Weinstein BM. 2002. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248: 307-318. http://dx.doi.org/10.1006/dbio.2002.0711
38. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent J-L, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. 2013. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580-637. http://dx.doi.org/ 10.1097/CCM.0b013e31827e83af
39. Lee WL, Slutsky AS. 2010. Sepsis and endothelial permeability. N Engl J Med 363:689-691. http://dx.doi.org/10.1056/NEJMcibr1007320
40. Benjamim CF, Hogaboam CM, Kunkel SL. 2004. The chronic consequences of severe sepsis. J Leukoc Biol 75:408-412. http://dx.doi.org/ 10.1189/jlb.0503214
41. Simmons J, Pittet JF. 2015. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 28:227-236 http://dx.doi.org/10.1097/ ACO.0000000000000163
42. Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA. 2013. Diagnosis and management for urosepsis. Int J Urol 20:963-970. http://dx.doi.org/10.1111/iju.12200
43. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. 2010. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect Larchmt 11:79-109. http://dx.doi.org/10.1089/sur.2009.9930
44. Cohen J. 2009. Non-antibiotic strategies for sepsis. Clin Microbiol Infect 15:302-307. http://dx.doi.org/10.1111/j.1469-0691.2009.02753.x
45. Stockhammer OW, Rauwerda H, Wittink FR, Breit TM, Meijer AH, Spaink HP. 2010. Transcriptome analysis of Traf6 function in the innate immune response of zebrafish embryos. Mol Immunol 48:179-190. http://dx.doi.org/10.1016/j.molimm.2010.08.011
46. Stockhammer OW, Zakrzewska A, Hegedûs Z, Spaink HP, Meijer AH. 2009. Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection. J Immunol 182:5641-5653. h t t p: / / d x . d o i . o r g / 1 0 . 4 0 4 9 / jimmunol.0900082
47. van der Sar AM, Spaink HP, Zakrzewska A, Bitter W, Meijer AH. 2009. Specificity of the zebrafish host transcriptome response to acute and chronic mycobacterial infection and the role of innate and adaptive immune components. Mol Immunol 46:2317-2332. http:// dx.doi.org/10.1016/j.molimm.2009.03.024
48. Huang Da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. http://dx.doi.org/10.1038/nprot.2008.211
49. Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. 2009. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 69:479-491. http:// dx.doi.org/10.1111/j.1365-3083.2009.02255.x
50. Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, Penfil S, Monaco M, Tagavilla MA, Odoms K, Dunsmore K, Barnes M, Aronow BJ, Genomics of Pediatric SSSI. 2007. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 30:146-155. http://dx.doi.org/ 10.1152/physiolgenomics.00024.2007
51. Weyand AC, Shavit JA. 2014. Zebrafish as a model system for the study of hemostasis and thrombosis. Curr Opin Hematol 21:418-422. http://dx.doi.org/10.1097/MOH.0000000000000075
52. Reinhardt HC, Schumacher B. 2012. The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet 28:128-136. http://dx.doi.org/10.1016/j.tig.2011.12.002
53. Tang BM, Huang SJ, McLean AS. 2010. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 14:R237. http://dx.doi.org/10.1186/cc9392
54. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. 2006. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 106:63-71. http://dx.doi.org/10.1016/j.imlet.2006.04.010
55. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF, Inflamm and Host Response to Injury Large Scale Collab. Res. Program. 2005. A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037. http://dx.doi.org/10.1038/ nature03985
56. Talwar S, Munson PJ, Barb J, Fiuza C, Cintron AP, Logun C, Tropea M, Khan S, Reda D, Shelhamer JH, Danner RL, Suffredini AF. 2006. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 25:203-215. http:// dx.doi.org/10.1152/physiolgenomics.00192.2005
57. Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, Penfil S, Monaco M, Odoms K, Barnes M, Sakthivel B, Aronow BJ, Wong HR. 2007. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 13:495-508. http://dx.doi.org/10.2119/2007-00065.Shanley
58. Johnson SB, Lissauer M, Bochicchio GV, Moore R, Cross AS, Scalea TM. 2007. Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg 245:611-621. http://dx.doi.org/10.1097/ 01.sla.0000251619.10648.32
59. Nduka OO, Parrillo JE. 2009. The pathophysiology of septic shock. Crit Care Clin 25:677-702, vii. http://dx.doi.org/10.1016/j.ccc.2009.08.002
60. Uhlar CM, Whitehead AS. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265:501-523. http:// dx.doi.org/10.1046/j.1432-1327.1999.00657.x
61. Zhang N, Ahsan MH, Purchio AF, West DB. 2005. Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. J Immunol 174:8125-8134. h t t p: / / d x . d o i . o r g / 1 0 . 4 0 4 9 / jimmunol.174.12.8125
62. Shah C, Hari-Dass R, Raynes JG. 2006. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108:1751-1757. http://dx.doi.org/10.1182/blood-2005-11-011932
63. Erman A, Lakota K, Mrak-Poljsak K, Blango MG, Krizan-Hergouth V, Mulvey MA, Sodin-Semrl S, Veranic P. 2012. Uropathogenic Escherichia coli induces serum amyloid A in mice following urinary tract and systemic inoculation. PLoS One 7:e32933. http://dx.doi.org/10.1371/ journal.pone.0032933
64. Nemeth E, Ganz T. 2009. The role of hepcidin in iron metabolism. Acta Haematol 122:78-86. http://dx.doi.org/10.1159/000243791
65. Renckens R, Roelofs JJ, Florquin S, de Vos AF, Lijnen HR, van't Veer C, van der Poll T. 2006. Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J Immunol 176:3735-3741. http://dx.doi.org/10.4049/jimmunol.176.6.3735
66. Cizmeci MN, Kara S, Kanburoglu MK, Simavli S, Duvan CI, Tatli MM. 2014. Detection of cord blood hepcidin levels as a biomarker for early-onset neonatal sepsis. Med Hypotheses 82:310-312. http:// dx.doi.org/10.1016/j.mehy.2013.12.017
67. Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, Huhle G, Borggrefe M, Brueckmann M. 2006. Matrixmetalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 38: 867-872. http://dx.doi.org/10.1080/00365540600702058
68. Edgar JD, Gabriel V, Gallimore JR, McMillan SA, Grant J. 2010. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr 10:22. http://dx.doi.org/ 10.1186/1471-2431-10-22
69. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA. 1989. Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710
70. Spittler A, Razenberger M, Kupper H, Kaul M, Hackl W, Boltz-Nitulescu G, Függer R, Roth E. 2000. Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clin Infect Dis 31:1338-1342. http://dx.doi.org/10.1086/317499
71. Remick DG, Bolgos G, Copeland S, Siddiqui J. 2005. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 73:2751-2757. http://dx.doi.org/10.1128/IAI.73.5.2751-2757.2005
72. Rossez Y, Wolfson EB, Holmes A, Gally DL, Holden NJ. 2015. Bacterial flagella: twist and stick, or dodge across the kingdoms. PLoS Pathog 11:e1004483. http://dx.doi.org/10.1371/journal.ppat.1004483
73. Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, Cookson BT, Aderem A. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4:1247-1253. http://dx.doi.org/ 10.1038/ni1011
74. Yoon SI, Kurnasov O, Natarajan V, Hong M, Gudkov AV, Osterman AL, Wilson IA. 2012. Structural basis of TLR5-flagellin recognition and signaling. Science 335:859-864. http://dx.doi.org/10.1126/ science.1215584
75. Lane MC, Alteri CJ, Smith SN, Mobley HL. 2007. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A 104:16669-16674. http:// dx.doi.org/10.1073/pnas.0607898104
76. Prajsnar TK, Renshaw SA, Ogryzko NV, Foster SJ, Serror P, Mesnage S. 2013. Zebrafish as a novel vertebrate model to dissect enterococcal pathogenesis. Infect Immun 81:4271-4279. http:// dx.doi.org/10.1128/IAI.00976-13
77. Musher DM. 1989. Cutaneous manifestations of bacterial sepsis. Hosp Pract (Off Ed) 24:71-75, 80-82, passim
78. Patel JK, Perez OA, Viera MH, Halem M, Berman B. 2009. Ecthyma gangrenosum caused by Escherichia coli bacteremia: a case report and review of the literature. Cutis 84:261-267
79. Liaudet L, Szabó C, Evgenov OV, Murthy KG, Pacher P, Virág L, Mabley JG, Marton A, Soriano FG, Kirov MY, Bjertnaes LJ, Salzman AL. 2003. Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock 19:131-137. http:// dx.doi.org/10.1097/00024382-200302000-00008
80. Barnea Y, Carmeli Y, Neville LF, Kahel-Reifer H, Eren R, Dagan S, Navon-Venezia S. 2009. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model. Burns 35:390-396. http://dx.doi.org/10.1016/ j.burns.2008.08.014
81. Neely CJ, Kartchner LB, Mendoza AE, Linz BM, Frelinger JA, Wolfgang MC, Maile R, Cairns BA. 2014. Flagellin treatment prevents increased susceptibility to systemic bacterial infection after injury by inhibiting anti-inflammatory IL-10α IL-12 neutrophil polarization. PLoS One 9:e85623. http://dx.doi.org/10.1371/journal.pone.0085623
82. Silva SC, Baggio-Zappia GL, Brunialti MK, Assunçao MS, Azevedo LC, Machado FR, Salomao R. 2014. Evaluation of Toll-like, chemokine, and integrin receptors on monocytes and neutrophils from peripheral blood of septic patients and their correlation with clinical outcomes. Braz J Med Biol Res 47:384-393. http://dx.doi.org/10.1590/1414-431X20143190
83. Abu-Maziad A, Schaa K, Bell EF, Dagle JM, Cooper M, Marazita ML, Murray JC. 2010. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 68:323-329. http:// dx.doi.org/10.1203/PDR.0b013e3181e6a068
84. Ramírez Cruz NE, Maldonado Bernal C, Cuevas ML, Castañoń J, López Macías C, Isibasi A. 2004. Toll-like receptors: dysregulation in vivo in patients with acute respiratory distress syndrome. Rev Alerg Mex 51:210-217
85. McDermott PF, Ciacci-Woolwine F, Snipes JA, Mizel SB. 2000. Highaffinity interaction between Gram-negative flagellin and a cell surface polypeptide results in human monocyte activation. Infect Immun 68: 5525-5529. http://dx.doi.org/10.1128/IAI.68.10.5525-5529.2000
86. Liu F, Yang J, Zhang Y, Zhou D, Chen Y, Gai W, Shi W, Li Q, Tien P, Yan H. 2010. Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy. Biochem Biophys Res Commun 392:582-587. http://dx.doi.org/ 10.1016/j.bbrc.2010.01.077
87. Torio CM, Andrews RM. 2013. National inpatient hospital costs: the most expensive conditions by payer, 2011: statistical brief #160. Healthcare Cost and Utilization Project, Rockville, MD
88. Simmons ML, Durham SH, Carter CW. 2012. Pharmacological management of pediatric patients with sepsis. AACN Adv Crit Care 23: 437-4 4 8 ; q u i z 449-45 0 . h t t p: / / d x . d o i . o r g / 1 0 . 1 0 9 7 / NCI.0b013e31826ddccd
89. Alhashash F, Weston V, Diggle M, McNally A. 2013. Multidrugresistant Escherichia coli bacteremia. Emerg Infect Dis 19:1699-1701. (Letter.) doi: http://dx.doi.org/10.3201/eid1910.130309
90. Banerjee R, Johnson JR. 2014. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 58:4997-5004. http://dx.doi.org/10.1128/ AAC.02824-14
91. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West Ma JMG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110:3507-3512 http:// dx.doi.org/10.1073/pnas.1222878110
92. Takao K, Miyakawa T. 2015. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 112:1167-1172 http://dx.doi.org/10.1073/pnas.1401965111:1-6
93. Dyson A, Singer M. 2009. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 37:S30-S37. http://dx.doi.org/10.1097/CCM.0b013e3181922bd3
94. Debnath I, Norton JP, Barber AE, Ott EM, Dhakal BK, Kulesus RR, Mulvey MA. 2013. The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli. Infect Immun 81:1450-1459. http://dx.doi.org/10.1128/IAI.01213-12
95. Prajsnar TK, Cunliffe VT, Foster SJ, Renshaw SA. 2008. A novel vertebrate model of Staphylococcus aureus infection reveals phagocytedependent resistance of zebrafish to non-host specialized pathogens. Cell Microbiol 10:2312-2325. http://dx.doi.org/10.1111/j.1462-5822.2008.01213.x
96. Kim BJ, Hancock BM, Del Cid N, Bermudez A, Traver D, Doran KS. 2015. Streptococcus agalactiae infection in zebrafish larvae. Microb Pathog 79:57-60. http://dx.doi.org/10.1016/j.micpath.2015.01.007
97. Novoa B, Bowman TV, Zon L, Figueras A. 2009. LPS response and tolerance in the zebrafish (Danio rerio). Fish Shellfish Immunol 26: 326-331. http://dx.doi.org/10.1016/j.fsi.2008.12.004
98. Dios S, Balseiro P, Costa MM, Romero A, Boltaña S, Roher N, Mackenzie S, Figueras A, Novoa B. 2014. The involvement of cholesterol in sepsis and tolerance to lipopolysaccharide highlighted by the transcriptome analysis of zebrafish (Danio rerio). Zebrafish 11:421-433. http://dx.doi.org/10.1089/zeb.2014.0995
99. Sepulcre MP, Alcaraz-Pérez F, López-Muñoz A, Roca FJ, Meseguer J, Cayuela ML, Mulero V. 2009. Evolution of lipopolysaccharide (LPS) recognition and signaling: fish TLR4 does not recognize LPS and negatively regulates NF-kappaB activation. J Immunol 182:1836-1845. http://dx.doi.org/10.4049/jimmunol.0801755
100. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E. 1999. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546-553
101. Cvijanovich N, Shanley TP, Lin R, Allen GL, Thomas NJ, Checchia P, Anas N, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Wong HR, Genomics of Pediatric SSSI. 2008. Validating the genomic signature of pediatric septic shock. Physiol Genomics 34:127-134. http://dx.doi.org/ 10.1152/physiolgenomics.00025.2008
102. Maslash-Hubbard A, El-wiher N, Shanley TP, Cornell TT. 2011. Negative regulators of the host response in sepsis. Open Inflamm J 4:61-66. http://dx.doi.org/10.2174/1875041901104010061
103. Wu TW, Tabangin M, Kusano R, Ma Y, Ridsdale R, Akinbi H. 2013. The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J Pediatr 162:67-71. http://dx.doi.org/10.1016/ j.jpeds.2012.06.010
104. Pyle A, Ibbett IM, Gordon C, Keers SM, Walker M, Chinnery PF, Baudouin SV. 2009. A common UCP2 polymorphism predisposes to stress hyperglycaemia in severe sepsis. J Med Genet 46:773-775. http://dx.doi.org/10.1136/jmg.2009.067173
105. Diczfalusy U, Olofsson KE, Carlsson AM, Gong M, Golenbock DT, Rooyackers O, Fläring U, Björkbacka H. 2009. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J Lipid Res 50:2258-2264. http://dx.doi.org/10.1194/jlr.M900107-JLR200
106. Bruegel M, Ludwig U, Kleinhempel A, Petros S, Kortz L, Ceglarek U, Holdt LM, Thiery J, Fiedler GM. 2012. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. Crit Care Med 40:1478-1486. http://dx.doi.org/ 10.1097/CCM.0b013e3182416f05